We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$526M
AUM Growth
+$2.73M
Cap. Flow
-$3.25M
Cap. Flow %
-0.62%
Top 10 Hldgs %
28.13%
Holding
250
New
19
Increased
91
Reduced
65
Closed
17

Top Buys

Rank Stock Value
1
RL icon
Ralph Lauren
RL
+$7.83M
2
CMI icon
Cummins
CMI
+$3.81M
3
GILD icon
Gilead Sciences
GILD
+$3.61M
4
NXPI icon
NXP Semiconductors
NXPI
+$2.89M
5
TRI icon
Thomson Reuters
TRI
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 19.61%
3 Financials 12.5%
4 Industrials 10.74%
5 Consumer Discretionary 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLTX
101
DELISTED
Fleetmatics Group PLC
FLTX
$1.15M 0.22%
37,750
+26,150
+225% +$832K
JAZZ icon
102
Jazz Pharmaceuticals
JAZZ
$15.8B
$1.15M 0.22%
7,150
IBM icon
103
IBM
IBM
$214B
$1.14M 0.22%
6,286
+448
+8% +$81.6K
MSFT icon
104
Microsoft
MSFT
$3.62T
$1.12M 0.21%
24,206
+1,000
+4% +$44.6K
NGS icon
105
Natural Gas Services Group
NGS
$469M
$1.08M 0.21%
45,050
+14,300
+47% +$418K
OMCL icon
106
Omnicell
OMCL
$1.71B
$1.06M 0.2%
38,875
+1,200
+3% +$32.9K
OSUR icon
107
OraSure Technologies
OSUR
$288M
$1.04M 0.2%
144,500
-8,500
-6% -$68K
BAC icon
108
Bank of America
BAC
$438B
$1.04M 0.2%
60,814
-25,590
-30% -$407K
DD
109
DELISTED
Du Pont De Nemours E I
DD
$1.03M 0.2%
15,139
SRCI
110
DELISTED
SRC Energy Inc
SRCI
$1.01M 0.19%
83,100
-11,400
-12% -$142K
AMRI
111
DELISTED
Albany Molecular Research Inc
AMRI
$970K 0.18%
43,950
+23,800
+118% +$487K
PPL
112
PPL Corp
PPL
$26.4B
$966K 0.18%
31,587
+4,075
+15% +$127K
AYI icon
113
Acuity Brands
AYI
$10B
$942K 0.18%
8,000
+325
+4% +$38.3K
SGMO
114
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$928K 0.18%
86,000
-18,750
-18% -$245K
IONS icon
115
Ionis Pharmaceuticals
IONS
$9.02B
$917K 0.17%
23,612
BCRX icon
116
BioCryst Pharmaceuticals
BCRX
$2.25B
$910K 0.17%
93,000
XOOM
117
DELISTED
XOOM CORP COM
XOOM
$907K 0.17%
41,325
+31,925
+340% +$735K
ELLI
118
DELISTED
Ellie Mae Inc
ELLI
$879K 0.17%
26,950
LULU icon
119
lululemon athletica
LULU
$14B
$866K 0.16%
20,620
-85,345
-81% -$3.44M
COP icon
120
ConocoPhillips
COP
$145B
$863K 0.16%
11,279
-915
-8% -$74.9K
ATRO icon
121
Astronics
ATRO
$3.51B
$861K 0.16%
32,942
+16,079
+95% +$440K
PEGA icon
122
Pegasystems
PEGA
$5.2B
$852K 0.16%
89,200
-6,000
-6% -$64.8K
INSM icon
123
Insmed
INSM
$21.4B
$845K 0.16%
64,729
+5,000
+8% +$75.4K
RARE icon
124
Ultragenyx Pharmaceutical
RARE
$2.46B
$845K 0.16%
14,925
-800
-5% -$40.3K
CTRL
125
DELISTED
Control4 Corporation
CTRL
$843K 0.16%
65,175
+15,050
+30% +$237K

Similar funds

Franklin Street Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Franklin Street Advisors held 250 positions worth $526M, up 0.52% from $523M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Franklin Street Advisors's Q3 2014 filing shows 19 new, 91 increased, 65 reduced and 17 closed positions. Its largest new stake was Ralph Lauren: 47,578 shares worth $7.84M. The largest sale was Diageo, an estimated $8.95M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q3 2014 buy was Ralph Lauren: 47,578 shares worth $7.84M.
  • Franklin Street Advisors added most to Gilead Sciences in Q3 2014, an estimated $3.61M increase.
  • Franklin Street Advisors's biggest Q3 2014 reduction was Diageo, cutting an estimated $8.95M.
  • Franklin Street Advisors fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014, selling an estimated $5.18M.
  • Franklin Street Advisors's ten largest holdings make up 28% of its $526M portfolio in Q3 2014.
  • Franklin Street Advisors opened 19 new positions and closed 17 in Q3 2014.
  • Franklin Street Advisors's portfolio value rose 0.52% quarter-over-quarter to $526M.

Based on Franklin Street Advisors's 13F filing for Q3 2014, filed 7 Oct 2014.